These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1005 related items for PubMed ID: 1902487

  • 1. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, Valdiserri A, Cognigni G.
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [Abstract] [Full Text] [Related]

  • 2. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M, Flamigni C, Campaniello E, Valdiserri A, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [Abstract] [Full Text] [Related]

  • 3. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 5. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L, Von Hagen S, Larkins D, Ibrahim J, Santoro N.
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA, Hall JE, Adams JM, Crowley WF.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [Abstract] [Full Text] [Related]

  • 10. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
    Filicori M, Flamigni C, Campaniello E, Meriggiola MC, Michelacci L, Valdiserri A, Ferrari P.
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730
    [Abstract] [Full Text] [Related]

  • 12. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N, Wierman ME, Filicori M, Waldstreicher J, Crowley WF.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [Abstract] [Full Text] [Related]

  • 13. Hypogonadotropic patients with ultrasonographically detected polycystic ovaries: endocrine response to pulsatile gonadotropin-releasing hormone.
    Schachter M, Balen AH, Patel A, Jacobs HS.
    Gynecol Endocrinol; 1996 Oct; 10(5):327-35. PubMed ID: 8915662
    [Abstract] [Full Text] [Related]

  • 14. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles.
    Filicori M, Flamigni C, Dellai P, Cognigni G, Michelacci L, Arnone R, Sambataro M, Falbo A.
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1215-20. PubMed ID: 7962297
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM, Collins RL, Hodgen GD.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [Abstract] [Full Text] [Related]

  • 17. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL, Farhi J, Homburg R, Jacobs HS.
    Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506
    [Abstract] [Full Text] [Related]

  • 18. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study.
    Fulghesu AM, Ciampelli M, Belosi C, Apa R, Guido M, Caruso A, Mancuso S, Lanzone A.
    J Endocrinol Invest; 2001 Aug; 24(7):483-90. PubMed ID: 11508781
    [Abstract] [Full Text] [Related]

  • 19. Pulsatile gonadotropin-releasing hormone therapy for ovulatory disorders.
    Santoro N, Elzahr D.
    Clin Obstet Gynecol; 1993 Sep; 36(3):727-36. PubMed ID: 8403619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.